Projekt

RICE: An open label, randomized study to compare the efficacy of Certolizumab pegol (CZP) plus a dynamic or fixed dose treatment strategy in patients with Rheumatoid Arthritis, a phase II study

Abgeschlossen · 2014 bis 2018

Müller Rüdiger, Forrer Silvia, Bartz-Batliner Mira, Schmidig Kathrin, Hutz Carina Liane